Comparative Efficacy of Induction-Concurrent Versus Concurrent-Adjuvant Chemoradiotherapy in High-Risk N2-N3 Nasopharyngeal Carcinoma: Insights from a Phase 3 Randomized Trial
Posted inClinical Updates Wellness & Lifestyle

Comparative Efficacy of Induction-Concurrent Versus Concurrent-Adjuvant Chemoradiotherapy in High-Risk N2-N3 Nasopharyngeal Carcinoma: Insights from a Phase 3 Randomized Trial

A phase 3 trial showed no significant difference in 3-year progression-free survival between induction-concurrent and concurrent-adjuvant chemoradiotherapy in treating high-risk N2-N3 nasopharyngeal carcinoma, with both regimens exhibiting manageable safety profiles.
Mupirocin Nasal Ointment Significantly Reduces Severe Acute Radiation Oral Mucositis in Nasopharyngeal Cancer Patients: Insights from a Phase 3 Trial
Posted inClinical Updates Wellness & Lifestyle

Mupirocin Nasal Ointment Significantly Reduces Severe Acute Radiation Oral Mucositis in Nasopharyngeal Cancer Patients: Insights from a Phase 3 Trial

A phase 3 trial demonstrates that mupirocin nasal ointment used for bacterial decolonization effectively lowers severe acute radiation oral mucositis rates, improves quality of life, and reduces Staphylococcus aureus colonization in nasopharyngeal cancer patients undergoing radiotherapy.